← Back to Search
A Systematic Review And Meta-analysis Of Surgical Treatments For Malignant Pleural Mesothelioma.
C. Cao, D. Tian, John Park, J. Allan, Kristopher A. Pataky, T. Yan
Published 2014 · Medicine
Download PDFAnalyze on Scholarcy
BACKGROUND Malignant pleural mesothelioma (MPM) is an aggressive disease of the pleural lining with a dismal prognosis. Surgical treatments of MPM with a curative intent include extrapleural pneumonectomy and extended pleurectomy/decortication (P/D). This meta-analysis aimed to compare the perioperative and long-term outcomes of EPP and extended P/D for selected surgical candidates. METHODS A systematic review of the literature was performed on six electronic databases to identify all relevant data on comparative outcomes of extended P/D and EPP in a multimodality setting. Endpoints included perioperative mortality and morbidity, as well as long-term overall survival. RESULTS Seven relevant studies with comparative data on EPP (n=632) versus extended P/D (n=513) were identified from the current literature. Comparison of these two groups demonstrated significantly lower perioperative mortality (2.9% vs. 6.8%, p=0.02) and morbidity (27.9% vs. 62.0%, p<0.0001) for patients who underwent extended P/D compared to EPP. Median overall survival ranged between 13-29 months for extended P/D and 12-22 months for EPP, with a trend favouring extended P/D. CONCLUSIONS Although it must be emphasized that patient selection and treatment strategies differ between EPP and extended P/D, a number of comparative studies have recently been conducted to compare these two surgical techniques for patients with resectable MPM. The present study indicated that selected patients who underwent extended P/D had lower perioperative morbidity and mortality with similar, if not superior, long-term survival compared to EPP, in the context of multi-modality therapy. This may represent an important paradigm shift in the surgical management of MPM.
This paper references
A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
M. Lucchi (2007)
Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma.
A. Nakas (2012)
Systematic review of trimodality therapy for patients with malignant pleural mesothelioma.
C. Cao (2012)
Malignant pleural mesothelioma: an epidemiological perspective.
Benjamin M. Robinson (2012)
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
T. Treasure (2011)
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
W. Weder (2007)
Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial
P. V. Van Schil (2010)
Radical surgery for malignant pleural mesothelioma: results and prognosis.
M. Okada (2008)
Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma: A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group
D. Rice (2011)
Mesothelioma: benefit from surgical resection is questionable.
T. Treasure (2007)
Systematic review of pleurectomy in the treatment of malignant pleural mesothelioma.
C. Cao (2013)
Surgery for mesothelioma: MARS landing and future missions.
T. Treasure (2010)
The Mars trial: resolution of the surgical controversies in mesothelioma?
Valerie Rusch (2009)
Quantifying heterogeneity in a meta-analysis.
J. Higgins (2002)
Landau Page 19 of 25 Ac ce pt ed M an us cr ip t 19
T Treasure (2011)
Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure.
O. Rena (2012)
Pleurectomy/Decortication is Superior to Extrapleural Pneumonectomy in the Multimodality Management of Patients with Malignant Pleural Mesothelioma
L. Lang-Lazdunski (2012)
Video-assisted thoracoscopic extrapleural pneumonectomy for malignant pleural mesothelioma.
T. Demmy (2012)
Changes in lung function after surgery for mesothelioma
T. Ploenes (2013)
A Systematic Review of Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma
C. Cao (2011)
Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication.
A. Wolf (2009)
Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results.
F. Rea (2007)
A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma.
L. Zellos (2009)
A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma.
Valerie Rusch (2007)
The MARS feasibility trial: conclusions not supported by data.
W. Weder (2011)
Summary of Prognostic Factors and Patient Selection for Extrapleural Pneumonectomy in the Treatment of Malignant Pleural Mesothelioma
Mbbs Christopher Cao BSc (2011)
The Mesothelioma and Radical Surgery Randomized Controlled Trial: The MARS Feasibility Study
T. Treasure (2009)
Which type of surgery should become the preferred procedure for malignant pleural mesothelioma: extrapleural pneumonectomy or extended pleurectomy?
M. A. Bedirhan (2013)
Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.
L. Krug (2009)
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
R. Flores (2008)
Extrapleural pneumonectomy and extended pleurectomy/decortication for malignant pleural mesothelioma: the Memorial Sloan-Kettering Cancer Center approach.
V. Rusch (2012)
This paper is referenced by
Outcomes of the Multimodal Treatment of Malignant Pleural Mesiothelioma: The Role of Surgery
Bub-Se Na (2018)
The effects of an intentional transition from extrapleural pneumonectomy to extended pleurectomy/decortication.
A. Sharkey (2016)
Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery
Edward J A Harris (2019)
Trimodality Treatment in Malignant Pleural Mesothelioma: An Ordeal or The Real Deal?
Naveen Mummudi (2020)
Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma.
Maurizio Infante (2016)
Treatment of malignant pleural mesothelioma: lessons learned and quo vadis?
S. Boeluekbas (2018)
Intracavitary cisplatin-fibrin chemotherapy after surgery for malignant pleural mesothelioma: A phase I trial.
I. Opitz (2019)
Prolonged post-recurrence survival following pleurectomy/decortication for malignant pleural mesothelioma.
Yuichiro Kai (2019)
Using Next-Generation Sequencing To Interrogate Circulating Tumour DNA In Thoracic Malignancies And As A Diagnostic Tool
Luke Martinson (2019)
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
I. Woolhouse (2018)
Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales
A. Linton (2014)
The Role of Surgery in Malignant Pleural Mesothelioma
Levon Toufektzian (2015)
Approved and emerging treatments of malignant pleural mesothelioma in elderly patients
Giovanni Luca Ceresoli (2019)
Surgery for mesothelioma: the evidence base and a pragmatic approach to surgical treatment
Vasudev Baburaya Pai (2017)
Intrapleural Photodynamic Therapy for Mesothelioma: What Place and Which Future?
C. Munck (2015)
Propensity matched comparison of extrapleural pneumonectomy and pleurectomy/decortication for mesothelioma patients.
Arthur Kostron (2017)
A new signal transducer and activator of transcription 3 inhibitor, BBI608, in malignant mesothelioma cell lines
T. Yamagishi (2019)
Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study
Angela Botticella (2016)
Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma.
Amar U. Kishan (2015)
Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England.
R. Damhuis (2015)
Surgery in Malignant Pleural Mesothelioma
R. Bueno (2018)
Modern Surgical Techniques in Malignant Pleural Mesothelioma
Yusuf Kahya (2016)
Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis
Z. Zhao (2017)
Malignant Mesothelioma: Has Anything Changed?
Roger Y Kim (2019)
Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma.
E. Taioli (2015)
A critical update on prognostic and predictive biomarkers in malignant pleural mesothelioma
Bahil Ghanim (2014)
Current surgical treatment of malignant pleural mesothelioma.
Koji Chihara (2018)
Surgical Outcomes and Risk Analysis of Primary Pulmonary Sarcoma.
Yoshito Yamada (2019)
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
M. Carbone (2019)
Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience.
M. Migliore (2015)
Improved Outcomes with Modern Lung‐Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma
F. Shaikh (2017)
Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation?
Angela Botticella (2017)See more